Company Profiles

driven by the PitchBook Platform

Gradientech

Gradientech
2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of microfluidic systems for analysis of the behavior of cells in response to gradients of signaling molecules. The company's technology enables the formation of stable gradients of soluble substance in any type of 2D and 3D cell culture setup.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
Dag Hammarskjölds väg 34A
752 37 Uppsala
Sweden

+ 46 (0)1 841 86 700
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gradientech’s full profile, request a free trial.

Gradientech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Jan-2013 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Gradientech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Almi Invest Corporate Venture Capital Minority 000 0000 000000 0
Stockholms Affärsänglar Angel Group Minority 000 0000 000000 0

You’re viewing 2 of 2 investors.

Gradientech Executive Team (2)

Name Title Board
Seat
Contact
Info
Sara Thorslund Ph.D Chief Executive Officer & Co-Founder
Ann-Sofie Andersson Manager, Sales & Marketing

You’re viewing 2 of 2 executives.

Gradientech Board Members (3)

Name Representing Role Since Contact
Info
Camilla Huse Bondesson Self Chairman 000 0000
Claes Tomas Post Ph.D Almi Invest Board Member 000 0000
Ted Elvhage Stockholms Affärsänglar Board Member 000 0000

You’re viewing 3 of 3 board members.